Company profile: Helius Medical
1.1 - Company Overview
Company description
- Provider of neurotechnology for neurological wellness, offering PoNS Therapy, a program combining the PoNS device with physical therapy to improve gait and balance deficits in patients with neurological conditions, and the PoNS Device, a non-implantable device delivering mild electrical tongue stimulation to promote neuroplasticity and improve motor function.
Products and services
- Non-implantable PoNS® Device: A tongue-placed medical device that delivers mild electrical stimulation to promote neuroplasticity and enhance motor function in patients with neurological disorders
- Physical therapy–integrated PoNS Therapy™: A therapeutic program combining the PoNS device with structured physical therapy to improve gait and balance deficits in patients with neurological conditions
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Helius Medical
Supernus Pharmaceuticals
HQ: United States
Website
- Description: Provider of specialty pharmaceutical products for central nervous system diseases, developing and commercializing therapies including Qelbree for ADHD; Trokendi XR for epilepsy and migraine prevention; and Oxtellar XR for epilepsy, with pipeline candidates SPN-830 for hypomobility in Parkinson’s disease, SPN-820/821 for treatment-resistant depression, and SPN-817 for severe epilepsy.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Supernus Pharmaceuticals company profile →
Neumentum
HQ: United States
Website
- Description: Provider of neurology specialty pharmaceutical solutions, developing and commercializing novel non-opioid pain products.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Neumentum company profile →
Rapport Therapeutics
HQ: United States
Website
- Description: Provider of precision medicines for neurological disorders, leveraging a RAP Technology Platform to discover and develop small-molecule therapies targeting specific neuronal receptor complexes. Programs include TARPγ8 AMPAR small molecules in clinical development for epilepsy with potential in pain and bipolar disorder, and discovery-stage nAChR modulators for chronic pain and hearing disorders.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Rapport Therapeutics company profile →
MAP Pharmaceuticals
HQ: United States
Website
- Description: Provider of novel inhalation therapies under development for respiratory and systemic diseases, with proprietary product candidates including Unit Dose Budesonide for pediatric asthma (children six months to eight years) and MAP0004 for migraine.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full MAP Pharmaceuticals company profile →
ADRx
HQ: United States
Website
- Description: Provider of a structure-based drug discovery platform that transforms atomic structures into small molecule therapies for protein aggregation diseases, targeting pathological protein structures. Develops small molecule modulators of protein-protein interactions, including amyloids and biomolecular condensates, and advances drug candidates for Alzheimer’s, systemic amyloidosis, ovarian cancer, ALS, and Parkinson’s.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full ADRx company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Helius Medical
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Helius Medical
2.2 - Growth funds investing in similar companies to Helius Medical
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Helius Medical
4.2 - Public trading comparable groups for Helius Medical
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →